メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
!!Link opens in a new tab
English
日本語
Keio Universityでコンテンツを検索
ホーム
プロファイル
研究部門
研究成果
Scopus著者プロファイル
涌井 昌俊
臨床検査医学
ウェブサイト
https://k-ris.keio.ac.jp/html/100006929_ja.html
h-index
1893
被引用数
22
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1991 …
2026
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(84)
類似のプロファイル
(6)
フィンガープリント
Masatoshi Wakuiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
84%
Vaccination Policy
58%
Vaccine Efficacy
50%
Adoptive Immunity
49%
Antibody Titer
36%
Humoral Immunity
33%
Monospecific Antibody
32%
Titer
28%
Immunoglobulin G Antibody
27%
Immune Response
27%
Mouse
25%
Hemodialysis
25%
T Cell
24%
Severe Acute Respiratory Syndrome
21%
Nucleotide Metabolism
21%
Virus Nucleocapsid
21%
Antibody Response
20%
Dynamics
19%
Booster Dose
17%
Interferon Gamma
15%
Spike
15%
Adjuvant
15%
Dendritic Cell
15%
Cell Population
14%
Antigen-Presenting Cell
14%
Parenchyma
13%
Population
13%
Liver Regeneration
12%
Neutralizing Antibody
12%
Upper Gastrointestinal Tract
10%
Platelet
10%
HLA DRB1 Antigen
10%
Viral Load
10%
Pemphigoid
10%
P53
10%
Immunoglobulin A
10%
Hepatic Progenitor Cell
10%
Inflammation Response
10%
Deamination
10%
Enzyme Immunoassay
10%
Receptor Editing
10%
Inflammatory Arthritis
10%
Omicron Coronavirus Variant
10%
Metabolome Analysis
10%
Metaphase
10%
Notch
10%
Vascular Tissue
10%
Immunoglobulin M
10%
Platelet Count
10%
Medicine and Dentistry
Adverse Event
43%
COVID-19 Vaccination
43%
Cellular Immunity
33%
Humoral Immunity
31%
Cohort Analysis
24%
Allogenic Bone Marrow Transplantation
21%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Disease
18%
COVID-19
18%
Recurrent Disease
14%
Chronic Myelogenous Leukemia
13%
Hemodialysis
12%
Intraductal Carcinoma
10%
Dry Eye
10%
Haemophilia A
10%
Emicizumab
10%
Bilirubin
10%
Metastatic Colon Cancer
10%
Imaging Mass Spectrometry
10%
Omicron Coronavirus Variant
10%
Surface Enhanced Raman Spectroscopy
10%
Transplantation
10%
Drug Metabolism
10%
Severe Acute Respiratory Syndrome
10%
Metaphase
10%
THP1 Cell Line
10%
Granulocyte Colony Stimulating Factor
10%
Observational Study
10%
Myelodysplastic Syndrome
10%
Recombinant Granulocyte Colony Stimulating Factor
10%
Hematopoietic Stem Cell Transplantation
10%
Interleukin 11
10%
Thrombopoietin
10%
Cancer
10%
Lewis Lung Carcinoma
10%
Breast Cancer
10%
Hematopoiesis
10%
Oxygen Consumption
10%
Thrombospondin 2
10%
Platelet
10%
Tritrichomonas Foetus
10%
Quadrupole Ion Trap
10%
Terpene
10%
Flavor
10%
(6) Gingerol
10%
Hepatic Veno-Occlusive Disease
10%
Pandemic
10%
Post-COVID-19
10%
Latent Class Analysis
10%
Infection
10%
Keyphrases
Clot Waveform Analysis
32%
Activated Partial Thromboplastin Time (aPTT)
21%
Upper Gastrointestinal Tract
10%
Prospective Evaluation
10%
Autoantibodies
10%
Microbial Protein
10%
Pemphigoid
10%
IgM Titer
10%
Genetic Dissection
10%
Functional Complementation
10%
Mesenteric Panniculitis
10%
Prostaglandin E-major Urinary Metabolite
10%
E484K mutation
10%
Semi-quantitative Analysis
10%
Imaging Mass Spectrometry
10%
Ancestral Strain
10%
Human Colon Cancer
10%
Hemostasis Monitoring
10%
Emicizumab
10%
NOG Mice
10%
Granulocyte Colony-stimulating Factor (G-CSF)
10%
Monovalent Vaccine
10%
Extractor
10%
Platelet Increment
10%
Hematopoietic Progenitor Cell Transplantation
10%
Myelodysplastic Syndrome
10%
Early Prognostication
10%
Receptor Editing
10%
IGH Rearrangement
10%
Coagulation Assays
10%
Pneumonia
10%
Humanized Liver
10%
Bivalirudin
10%
O2 Measurement
10%
Molecular Remission
10%
Chemiluminescent Enzyme Immunoassay (CLEIA)
10%
Allogeneic Bone Marrow Transplantation
10%
Adjuvant Activity
10%
Catabolites
10%
Amino Acids
10%
Fibroblast Cells
10%
Lewis Lung Carcinoma
10%
Carcinoma Progression
10%
Patients with COVID-19
10%
Preemptive Therapy
10%
Risk-adapted
10%
Cytomegalovirus Disease
10%
CMV Antigenemia
10%
Pemphigus
10%
Microenvironment Change
10%
